Drug Profile
Ilodecakin
Alternative Names: Human recombinant interleukin 10; Interleukin-10; Prevascar; rhIL-10; rIL-10; SCH-52000Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Schering-Plough
- Developer Renovo
- Class Anti-inflammatories; Antineoplastics; Immunotherapies; Interleukins
- Mechanism of Action Interleukin-10 replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acute lung injury; Autoimmune disorders; Cancer; Crohn's disease; Graft-versus-host disease; Growth disorders; Hepatic fibrosis; Hepatitis C; Herpes simplex virus infections; HIV infections; Multiple sclerosis; Myocarditis; Pancreatitis; Psoriasis; Reperfusion injury; Rheumatoid arthritis; Scars; Sepsis; Transplant rejection; Type 1 diabetes mellitus; Ulcerative colitis